What Researchers Did
Researchers evaluated a modified hyperbaric oxygen therapy (HBO2) protocol in two cases of pneumatosis cystoides intestinalis (PCI).
What They Found
The study observed favorable results in both of the two pneumatosis cystoides intestinalis (PCI) cases treated with their modified hyperbaric oxygen therapy (HBO2) protocol. The modified protocol aimed to address the risk of aggravation in PCI cases caused by pulmonary mechanisms, which can occur with standard HBO2.
What This Means for Canadian Patients
For Canadian patients diagnosed with pneumatosis cystoides intestinalis (PCI), this modified hyperbaric oxygen therapy (HBO2) protocol could potentially offer a non-invasive treatment option. This approach might be particularly beneficial for patients whose PCI is not caused by pulmonary mechanisms, where standard HBO2 could be risky.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.
Study Limitations
A significant limitation of this study is its extremely small sample size, involving only two patient cases.